Skip to main content

Page of 3
and
  1. No Access

    Book

    Problems and Pitfalls in Medical Literature

    A Practical Guide for Clinicians

    Adam L. Cohen (2023)

  2. No Access

    Article

    Consolidation regimens in primary central nervous system lymphoma: a single-center retrospective cohort evaluating survival outcomes and cost–benefit analysis

    Optimal treatment for primary central nervous system lymphoma (PCNSL) comprises polychemotherapy induction with high-dose methotrexate followed by consolidation therapy, but there is no standard treatment regi...

    Savannah Gelhard, Amiee Maxwell, Howard Colman, Adam L. Cohen in Journal of Neuro-Oncology (2022)

  3. Article

    Open Access

    Correction to: Caregiver burden by treatment and clinical characteristics of patients with glioblastoma

    Trang H. Au, Connor Willis, Maija Reblin, Katherine B. Peters in Supportive Care in Cancer (2022)

  4. Article

    Open Access

    Caregiver burden by treatment and clinical characteristics of patients with glioblastoma

    Glioblastoma is an incurable disease with a poor prognosis. For caregivers of people with glioblastoma, the burden of care can be high. Patients often present with different clinical characteristics, which may...

    Trang H. Au, Connor Willis, Maija Reblin, Katherine B. Peters in Supportive Care in Cancer (2022)

  5. Article

    Open Access

    Novel temporal and spatial patterns of metastatic colonization from breast cancer rapid-autopsy tumor biopsies

    Metastatic breast cancer is a deadly disease with a low 5-year survival rate. Tracking metastatic spread in living patients is difficult and thus poorly understood.

    **aomeng Huang, Yi Qiao, Samuel W. Brady, Rachel E. Factor in Genome Medicine (2021)

  6. No Access

    Article

    Serial single-cell genomics reveals convergent subclonal evolution of resistance as patients with early-stage breast cancer progress on endocrine plus CDK4/6 therapy

    Combining cyclin-dependent kinase (CDK) inhibitors with endocrine therapy improves outcomes for patients with metastatic estrogen receptor-positive breast cancer but its value in earlier-stage patients is uncl...

    Jason I. Griffiths, **feng Chen, Patrick A. Cosgrove, Anne O’Dea in Nature Cancer (2021)

  7. Article

    Open Access

    Evolution of core archetypal phenotypes in progressive high grade serous ovarian cancer

    The evolution of resistance in high-grade serous ovarian cancer (HGSOC) cells following chemotherapy is only partially understood. To understand the selection of factors driving heterogeneity before and throug...

    Aritro Nath, Patrick A. Cosgrove, Hoda Mirsafian in Nature Communications (2021)

  8. Article

    Open Access

    Association between the 21-gene recurrence score and isolated locoregional recurrence in stage I-II, hormone receptor-positive breast cancer

    Although the 21-gene recurrence score (RS) assay is widely used to predict distant recurrence risk and benefit from adjuvant chemotherapy among women with hormone receptor-positive (HR+) breast cancer, the rel...

    David D. Yang, Daniela L. Buscariollo, Angel M. Cronin, Shicheng Weng in Radiation Oncology (2020)

  9. Article

    Open Access

    Repeat radiation with bevacizumab and minocycline in bevacizumab-refractory high grade gliomas: a prospective phase 1 trial

    There are no effective treatments for gliomas after progression on radiation, temozolomide, and bevacizumab. Microglia activation may be involved in radiation resistance and can be inhibited by the brain penet...

    Adam L. Cohen, Christopher J. Anker, Brett Johnson in Journal of Neuro-Oncology (2020)

  10. No Access

    Article

    A multicenter phase II study of temozolomide plus disulfiram and copper for recurrent temozolomide-resistant glioblastoma

    Preclinical studies have suggested promising activity for the combination of disulfiram and copper (DSF/Cu) against glioblastoma (GBM) including re-sensitization to temozolomide (TMZ). A previous phase I study...

    Jiayi Huang, Rekha Chaudhary, Adam L. Cohen, Karen Fink in Journal of Neuro-Oncology (2019)

  11. Article

    Open Access

    The contribution of the rs55705857 G allele to familial cancer risk as estimated in the Utah population database

    IDH1/2 mutated glioma has been associated with a germline risk variant, the rs55705857 G allele. The Utah Population Database (UPDB), a computerized genealogy of people in Utah, is a unique resource to evaluate c...

    Sarah Hummel, Wendy Kohlmann, Thomas M. Kollmeyer, Robert Jenkins in BMC Cancer (2019)

  12. No Access

    Article

    Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma

    Glioblastoma is the most common primary malignant brain tumor in adults and is associated with poor survival. The Ivy Foundation Early Phase Clinical Trials Consortium conducted a randomized, multi-institution...

    Timothy F. Cloughesy, Aaron Y. Mochizuki, Joey R. Orpilla, Willy Hugo in Nature Medicine (2019)

  13. Article

    Open Access

    Responses to hypothetical health scenarios overestimate healthcare utilization for common infectious syndromes: a cross-sectional survey, South Africa, 2012

    Asking people how they would seek healthcare in a hypothetical situation can be an efficient way to estimate healthcare utilization, but it is unclear how intended healthcare use corresponds to actual healthca...

    Karen K. Wong, Adam L. Cohen, Neil A. Martinson, Shane A. Norris in BMC Infectious Diseases (2018)

  14. Article

    Open Access

    Publisher Correction: Combating subclonal evolution of resistant cancer phenotypes

    The originally published version of this Article contained an error in Figure 4. In panel a, grey boxes surrounding the subclones associated with patients #2 and #4 obscured adjacent portions of the heatmap. T...

    Samuel W. Brady, Jasmine A. McQuerry, Yi Qiao, Stephen R. Piccolo in Nature Communications (2018)

  15. Article

    Open Access

    Combating subclonal evolution of resistant cancer phenotypes

    Metastatic breast cancer remains challenging to treat, and most patients ultimately progress on therapy. This acquired drug resistance is largely due to drug-refractory sub-populations (subclones) within heter...

    Samuel W. Brady, Jasmine A. McQuerry, Yi Qiao, Stephen R. Piccolo in Nature Communications (2017)

  16. Article

    Glioma Subclassifications and Their Clinical Significance

    The impact of targeted therapies in glioma has been modest. All the therapies that have demonstrated a significant survival benefit for gliomas in Phase III trials, including radiation, chemotherapy (temozolom...

    Ricky Chen, Matthew Smith-Cohn, Adam L. Cohen, Howard Colman in Neurotherapeutics (2017)

  17. No Access

    Article

    New Molecular Considerations for Glioma: IDH, ATRX, BRAF, TERT, H3 K27M

    This review will discuss the role of several key players in glioma classification and biology, namely isocitrate dehydrogenase 1 and 2 (IDH1/2), alpha thalassemia/mental retardation syndrome X-linked (ATRX), B...

    Michael Karsy, Jian Guan, Adam L. Cohen in Current Neurology and Neuroscience Reports (2017)

  18. Article

    Open Access

    Development of a respiratory severity score for hospitalized adults in a high HIV-prevalence setting—South Africa, 2010–2011

    Acute lower respiratory tract infections (LRTI) are a frequent cause of hospitalization and mortality in South Africa; however, existing respiratory severity scores may underestimate mortality risk in HIV-infe...

    Alexander J. Millman, Adena Greenbaum, Sibongile Walaza in BMC Pulmonary Medicine (2017)

  19. Article

    Open Access

    Gene-expression patterns in peripheral blood classify familial breast cancer susceptibility

    Women with a family history of breast cancer face considerable uncertainty about whether to pursue standard screening, intensive screening, or prophylactic surgery. Accurate and individualized risk-estimation ...

    Stephen R. Piccolo, Irene L. Andrulis, Adam L. Cohen, Thomas Conner in BMC Medical Genomics (2015)

  20. Article

    Open Access

    Assessing the impact of pneumococcal conjugate vaccines on invasive pneumococcal disease using polymerase chain reaction-based surveillance: an experience from South Africa

    The use of molecular diagnostic techniques for the evaluation of the impact of pneumococcal conjugate vaccines (PCVs) has not been documented. We aimed to evaluate the impact of PCVs on invasive pneumococcal d...

    Stefano Tempia, Nicole Wolter, Cheryl Cohen, Sibongile Walaza in BMC Infectious Diseases (2015)

Page of 3